Blood cancer is often invisible and undetectable to the touch. According to data from the National Health Agency’s cancer registry, 3,213 people were newly diagnosed with malignant lymphoma in 2013, while 1,963 were diagnosed with leukemia. In total, 5,166 new cases of blood cancer are diagnosed annually—meaning approximately 1 in every 20 cancer patients in Taiwan is fighting blood cancer.
Many people mistakenly equate blood cancer solely with leukemia. In reality, it encompasses three major categories and up to nine subtypes of hematologic malignancies, including lymphoma, leukemia, multiple myeloma, and myelodysplastic syndromes. For instance:
Lymphoma has affected public figures such as entertainers A-Pang and Billie, writer Huang Chun-ming, Blood Foundation Chairman Yeh Chin-chuan, and former Google VP Kai-Fu Lee.
Leukemia has impacted figures like Terry Gou’s younger brother Gou Cheng-ping, illustrator Jimmy, BELLAVITA chairman Liang Hsiu-ching, and entertainer Frankie Kao.
Multiple myeloma claimed the life of Shih Hsin University founder Lucie Cheng.
This silent cancer is rapidly rising in prevalence, with nearly 5,000 new cases annually, making it the sixth most common malignant tumor in Taiwan.
Three Decades of Breakthroughs in Treatment
Since the 1990s, blood cancer treatment has achieved revolutionary advances each decade:
1990s: Bone Marrow Transplants as a Lifeline
Bone marrow transplantation was once the only hope for survival. Previously, a fully matched donor was essential; today, even half-matched or parent-child donations can succeed.
2000s: Targeted Therapies and Precision Medicine
The advent of drugs like imatinib for chronic myeloid leukemia (CML) transformed outcomes. Patients no longer rely solely on chemotherapy or transplants but can manage the disease with oral targeted drugs, living normally—working, marrying, and raising children.
2010s–Present: Immunotherapy and Cellular Advances
Treatment has expanded beyond stem cell transplants to immunotherapies like CAR-T cell therapy, dramatically boosting cure prospects.
Key to Survival: Early and Active Treatment
With medical advancements, blood cancer is no longer a terminal illness. Patients who seek prompt and aggressive treatment upon diagnosis significantly increase their chances of cure. For example:
Childhood acute lymphoblastic leukemia (ALL) now has a >90% 5-year survival rate with modern protocols.
Hodgkin’s lymphoma achieves cure rates exceeding 90% through combined radiotherapy, chemotherapy, and immunotherapy.
A Call to Action
Blood cancer’s invisibility makes awareness critical. Recognizing symptoms—such as unexplained fatigue, bruising, frequent infections, or weight loss—and seeking immediate medical evaluation can save lives. Today, a diagnosis is not an end but a call to action: with innovative therapies, multidisciplinary care, and sustained hope, beating blood cancer is increasingly achievable.